Substituted indazolyl(indolyl)maleimide derivatives as kinase inhibitors

Details for Australian Patent Application No. 2004251178 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Maryanoff, Bruce E.; Zhang, HanCheng; Ye, Hong

Agent Shelston IP

Pub. Number AU-A-2004251178

PCT Pub. Number WO2005/000836

Priority 60/478,516 13.06.03 US

Filing date 1 June 2004

Wipo publication date 6 January 2005

International Classifications

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

5 January 2006 PCT application entered the National Phase

  PCT publication WO2005/000836 Priority application(s): WO2005/000836

24 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004251181-Regulation of kinase, /regulated in COPD kinase/ (RC kinase)

2004251176-Cyclohexyl derivatives as selective estrogen receptor modulators